Skip to search.
 TSX Down 0.97% TSX Ventures Down 0.18%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
107.36 Down 1.06(0.98%) 1:47PM EST - Nasdaq Real Time Price
Add to Portfolio
Prev Close:108.42
Open:107.21
Bid:107.19 x 100
Ask:107.31 x 100
1y Target Est:118.74
Beta:1.14
Earnings Date:Apr 29 - May 4 (Est.)
Day's Range:106.07 - 108.00
52wk Range:55.04 - 111.89
Volume:678,397
Avg Vol (3m):1,269,680
Market Cap:16.01B
P/E (ttm):N/A
EPS (ttm):-0.92
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BMRNDown 0.98%16.01B
FOLD 0.00%670.26M
SHPGUp 0.34%46.41B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):21.52
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-2.24
Quarterly EPS Est (Mar-15) :-0.53
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-1.94

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback